COMPUGEN LTD (CGEN) [Rocket]

Date Filed	Type	Description
12/12/2019	GN	Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors
06/25/2012	PRN	Compugen und Merck Serono Ventures gründen neues Biomarker-Unternehmen Neviah Genomics
05/19/2011	BW	Compugen Discloses Discovery Method for Drug Candidates That Interfere With Protein Conformations
05/11/2011	BW	Compugen Reports First Quarter 2011 Financial Results
05/03/2011	BW	Compugen First Quarter 2011 Webcast and Conference Call Scheduled for Wednesday, May 11, 2011 at 10:00 AM EDT
04/27/2011	BW	Compugen Discloses Splice Variant Based Program to Discover Superior Oncology Drug Targets for mAb Therapy
03/07/2011	BW	Compugen Announces Positive Animal Model Results for Novel Peptide Predicted to Block Protein-Protein Interaction
02/15/2011	BW	Compugen Ltd. Reports Fourth Quarter and Calendar 2010 Financial Results
12/14/2010	BW	Compugen Announces Positive Therapeutic Effect of CGEN-15001 in Animal Model of Rheumatoid Arthritis
12/06/2010	BW	New Studies Support Therapeutic Potential of Compugen Discovered Target for Multiple Myeloma Treatment
11/22/2010	BW	Compugen Announces Discovery Platform for New Members of Protein Families with Known Therapeutic Applications
10/29/2010	BW	Compugen Licenses Novel Oncology Target to Seattle Genetics
10/26/2010	BW	Compugen Reports Third Quarter 2010 Financial Results
10/19/2010	BW	Compugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
07/27/2010	BW	Compugen Reports Second Quarter 2010 Financial Results
07/01/2010	BW	Compugen Discovered Protein Shown to Abolish Recurring Relapses in Multiple Sclerosis Animal Model
05/03/2010	BW	Compugen to Host Q&A Conference Call on Wednesday, May 5, 2010 at 10:00 AM EDT
04/27/2010	BW	Compugen Reports First Quarter 2010 Financial Results
04/22/2010	BW	Compugen Announces New Drug Discovery Platform to Predict Peptides that Block Protein – Protein Interactions
04/19/2010	BW	Compugen First Quarter 2010 Webcast and Conference Call Scheduled for Tuesday, April 27, 2010 at 10:00 AM EDT
03/16/2010	BW	Compugen Announces Discovery Platform to Predict Cell Penetrating Peptides for Drug Delivery